Fluorescite

Active Ingredient(s): Fluorescein
FDA Approved: * March 28, 2006
Pharm Company: * ALCON RES
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Fluorescite Overview

Fluorescein is a manufactured organic compound and dye. It is available as a dark orange/red powder slightly soluble in water and alcohol. It is widely used as a fluorescent tracer for many applications. Fluorescein is a fluorophore commonly used in microscopy, in a type of dye laser as the gain medium, in forensics and serology to detect latent blood stains, and in dye tracing. Fluorescein has an absorption maximum at 494nm and emission maximum of 512nm (in water). The major derivatives are ...

Read more Fluorescite Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fluorescein

Recent Fluorescite Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fluorescein
  • Injection: 10%, 100mg/ml, 25%, 250mg/ml, 500mg/2ml (250mg/ml), 500mg/2ml(250mg/ml), 500mg/5ml (100mg/ml), 500mg/5ml(100mg/ml)
  • Insert: 1mg, 9mg
  • Ophthalmic Strip: 0.6mg, 1mg
  • Solution: 0.25%, 10%, 2%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fluorescite: (1 result)

Sorted by National Drug Code
  • 0065-0092 Fluorescite 100 mg/ml Ophthalmic Injection, Solution by Alcon, Inc.

Other drugs which contain Fluorescein or a similar ingredient: (11 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA